The Effect of Regional Anaesthesia and Genetic Factors in the Development of Chronic Pain Following Total Knee Arthroplasty

Sponsor
Sciberras, Stephen M.D. (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04206046
Collaborator
(none)
200
1
2
78.9
2.5

Study Details

Study Description

Brief Summary

The study aims to assess the effect of spinal anaesthesia against a general anaesthesia with a femoral block, with respect to the incidence of chronic pain following a total knee replacement.

It will also focus on genetic factors and their influence on chronic pain.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Spinal anaesthesia
  • Procedure: General anaesthesia
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Effect of Regional Anaesthesia and Genetic Factors in the Development of Chronic Pain Following Total Knee Arthroplasty
Actual Study Start Date :
Jun 1, 2017
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Dec 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: General Anaesthesia

Patients will receive a general anaesthetic, together with a femoral nerve block.

Procedure: General anaesthesia
patients will receive a general anaesthetic and a femoral nerve block

Active Comparator: Spinal Anaesthesia

Patients will receive a spinal anaesthetic

Procedure: Spinal anaesthesia
Patients will receive a spinal anaesthetic

Outcome Measures

Primary Outcome Measures

  1. Pain Numerical Rating Scale on physiotherapy [24 hours]

    Pain Numerical Rating Scale, from 0 (no pain) to 10 (severe pain)

  2. WOMAC Score at 3 and at 6 months [6 months]

    WOMAC score, ranging from 0 to 94

  3. WOMAC Pain Score at 3 and at 6 months [6 months]

    WOMAC Pain score, ranging from 0 (no pain) to 20 (severe pain on numerous activities)

Secondary Outcome Measures

  1. Morphine consumption [24 hours]

    Morphine use postop

  2. Pain Numerical Rating Scale after 6 months [6 months]

    Pain Numerical Rating Scale at rest, from 0 (no pain) to 10 (severe pain)

  3. Incidence of Chronic Post-surgical Pain [6 months]

    WOMAC pain score greater than 5 at 6 months (out of total of 20)

  4. Change in WOMAC Score at 3 and at 6 months [6 months]

    change in WOMAC score, ranging from 0 to 94

  5. Change in WOMAC Pain Score at 3 and at 6 months [6 months]

    change in WOMAC Pain score, ranging from 0 (no pain) to 20 (severe pain on numerous activities)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients able to undergo a total knee arthroplasty
Exclusion Criteria:
  • age more than 75 years

  • known case of chronic pain syndromes

  • arthroplasty not due to osteoarthritis

  • sensitivity to any drugs used in protocol

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mater Dei Hospital Imsida Malta MSD2090

Sponsors and Collaborators

  • Sciberras, Stephen M.D.

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Stephen Sciberras, Lead investigator, Sciberras, Stephen M.D.
ClinicalTrials.gov Identifier:
NCT04206046
Other Study ID Numbers:
  • 001
First Posted:
Dec 20, 2019
Last Update Posted:
Sep 13, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Stephen Sciberras, Lead investigator, Sciberras, Stephen M.D.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2021